Discover the latest advancements in multiple sclerosis (MS) treatment, including innovative therapies and strategies for ...

The FDA fast-tracks birelentinib, a dual inhibitor for relapsed CLL/SLL, promising new hope for patients facing treatment ...

Q2 2025 Management View John V. Oyler, CEO, reported "Our revenue reached $1.3 billion, which represents 42% year-on-year growth. GAAP earnings per ADS grew $2 from Q2 of last year, and we generated ...

Pirtobrutinib had a nominally superior overall response rate compared to ibrutinib in certain patients with chronic ...

"BTK: Confession of a Serial Killer" premieres Saturday, Jan. 8 at 9 p.m. ET on A&E. The Associated Press contributed to this report. Stephanie Nolasco covers entertainment at Foxnews.com.

The newest BTK inhibitor on the market, Eli Lilly’s Jaypirca, has s | In a phase 3 trial, the newest Bruton’s tyrosine kinase ...

Eli Lilly said on Tuesday its drug for a type of blood cancer was more effective in a head-to-head study against AbbVie's ...

A law enforcement team in northeast Oklahoma believes the prolific serial killer known as “BTK” may be responsible for several additional unsolved missing person and homicide cases. Now they ...

The woman in one of BTK’s drawings is believed to be a woman who vanished on 1991, a sheriff says. Osage County Sheriff's Office While Virden would not disclose additional details about her ...

Serial killer Dennis Rader, known as BTK, was reportedly visited in prison by Oklahoma investigators about a 1976 cold case, but Rader's daughter doesn't believe he was responsible ...

BTK’s next victims were all young women found strangled in their homes. He told how he let some women smoke or have a glass of water to put them at ease before he killed them.

Regarding this, BTK says he was led to commit his horrific crimes by two potential masters. The first, a demon he calls the "X-factor," he says is inside him, making him do what he did.